简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

SHAREHOLDER ALERT: Investigation of Odonate Announced by Holzer & Holzer, LLC

2020-08-26 19:44

Holzer & Holzer, LLC is investigating whether Odonate Therapeutics, Inc. (“Odonate” or the “Company”) (NASDAQ: ODT) complied with federal securities laws. On August 24, 2020, Odonate issued a press release announcing top-line results from the Company's CONTESSA trial. The price of Odonate’s stock fell following the announcement.

If you purchased shares of Odonate and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Luke R. Kennedy, Esq. at lkennedy@holzerlaw.com , or by toll-free telephone at (888) 508-6832 to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。